Trial Profile
Retrospective study of deferasirox on haematopoiesis in a large 'real-world' myelodysplastic syndromes (MDS) population
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 31 Aug 2016
Price :
$35
*
At a glance
- Drugs Deferasirox (Primary)
- Indications Myelodysplastic syndromes
- Focus Adverse reactions; Therapeutic Use
- 31 Mar 2016 New trial record